Impact of Lactobacillus reuteri DSM 17938 on infant colic and parent mental health: a randomised double-blinded, placebo-controlled trial in breast and formula fed infants less than 3 months old

Murdoch Childrens Research Institute (MCRI) (Australia)0 个研究点目标入组 160 人开始时间: 2010年10月25日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•Infants less than 3 months old (up to and excluding 13.0 weeks) with:
•1. Infant colic, ie crying more than 3 hours/day for more than 3 days over 7 days (as defined by the modified Wessel's criteria) by caregiver's report
•2. More than 36 weeks gestation at birth
•3. Birth weight more than 2500 g

•1. Infants with failure to thrive (weight gain less than 20 g/day averaged from birth to the last recorded weight)
•2. Infants with major medical problems (eg. ill, immunocompromised, infants with major developmental or chromosomal abnormalities)
•3. Infants or breastfeeding mothers using antibiotics or probiotics at the time of study recruitment
•4. Families with insufficient English to understand informed consent or complete questionnaires

发起方

Murdoch Childrens Research Institute (MCRI) (Australia)